Merck Consumer Healthcare
This article was originally published in The Tan Sheet
Executive Summary
John Irvin, MD/PhD, is named VP- worldwide OTC development. Irvin will serve as the "primary liaison" to joint venture partner Johnson & Johnson and as executive director of worldwide OTC clinical and regulatory development for Merck Research Labs.